Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs
The technology of a prodrug, doxorubicin, is applied in the preparation and application of folic acid-mediated tumor-targeting doxorubicin prodrug, which can solve the problems of cytotoxicity limitation, tumor cell drug resistance, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0036] Study on Antitumor Activity of Doxorubicin Prodrugs in Vitro
[0037] 1. Purpose:
[0038] The antitumor activity of the prodrug was evaluated by in vitro experiments with doxorubicin as a positive control.
[0039] 2 Research methods:
[0040] 2.1 In vitro cytotoxicity evaluation of prodrugs
[0041] Dissolve the various drugs to be tested in serum-free culture medium (DMSO less than 0.1%) according to the set concentration, and use 0.25% trypsin to digest KB cells with high expression of folic acid and folic acid in the logarithmic growth phase. Negatively expressed A549 cells were seeded in 96-well plates at a density of 1×10 4 After culturing for 24 hours, DOX, FA-AMA-DOX, and DOX-hyd-PEG-FA were added at 0.001, 0.01, 0.1, 1, and 10 μM (concentrations of doxorubicin) respectively (the culture medium without serum was blank Control), after incubation for 24h / 48h, add 20μL MTT and continue to incubate for 4h, discard the culture medium, redissolve the purple crys...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
